Early Acetaminophen-Protein Adducts Predict Hepatotoxicity Following Overdose.
Acetaminophen-protein adducts are a specific biomarker of toxic acetaminophen (paracetamol) metabolite exposure. In patients with hepatotoxicity (ALT>1000U/L), a concentration >1.0nmol/mL is sensitive and specific in identifying cases secondary to acetaminophen. Our aim was to characterise acetaminophen-protein adduct concentrations in patients following acetaminophen overdose and determine if they predict toxicity. A multi-centre prospective observational study, recruiting patients ≥14 years with acetaminophen overdose regardless of intent or formulation. Three serum samples were obtained within the first 24h of presentation and analysed for acetaminophen-protein adducts. Acetaminophen-protein adduct concentrations were compared to ALT and other indicators of toxicity. 240 patients participated, and 1009 samples were analysed. 204(85%) were acute ingestions with a median ingested dose of 20g(IQR:10-40). 228(95%) were treated with intravenous acetylcysteine at a median time of 6h(IQR:3.5-10.5) post-ingestion. 36(15%) patients developed hepatotoxicity, of which 22 had an ALT≤1000 U/L at the time of initial acetaminophen-protein adduct measurement. Those who developed hepatotoxicity had a higher initial acetaminophen-protein adduct concentration vs those who didn't, 1.63nmol/mL (IQR:0.76-2.02, n=22) vs. 0.26nmol/mL (IQR:0.15-0.41, n=204)(p<0.0001), respectively. The ROCAUC for acetaminophen-protein adducts and ALT for prediction of hepatotoxicity in these patients was 0.98 (95%CI:0.96-1.00, n = 226, p<0.0001) and 0.89 (95%CI:0.82 - 0.96, n=219, p<0.0001) respectively. An acetaminophen-protein adduct concentration of 0.58nmol/mL was 100% sensitive and 91% specific for identifying patients that would develop hepatotoxicity, who presented with an initial ALT<1000U/L. When utilised in risk prediction models the addition of acetaminophen-protein adducts to initial ALT and time to presentation improved prediction of hepatotoxicity. The improvement was similar to that obtained from more complex prediction models including time adjusted acetaminophen concentrations. Acetaminophen-protein adduct concentration on presentation predicted which patients with acetaminophen overdose subsequently developed hepatotoxicity, regardless of time of ingestion, or intent. An adduct threshold of 0.58nmol/L was required for optimal prediction.